Triniti C Turner1, Charles Arama2, Aissata Ongoiba2, Safiatou Doumbo2, Didier Doumtabé2, Kassoum Kayentao2, Jeff Skinner1, Shanping Li1, Boubacar Traore2, Peter D Crompton3, Anton Götz4. 1. Malaria Infection Biology and Immunity Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, 20852, USA. 2. Malaria Research and Training Centre, Department of Epidemiology of Parasitic Diseases, International Center of Excellence in Research, University of Sciences, Technique, and Technology of Bamako, 91094, Bamako, Mali. 3. Malaria Infection Biology and Immunity Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, 20852, USA. pcrompton@niaid.nih.gov. 4. Malaria Infection Biology and Immunity Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, 20852, USA. anton.goetz@nih.gov.
Abstract
BACKGROUND: Plasmodium falciparum causes the majority of malaria cases worldwide and children in sub-Saharan Africa are the most vulnerable group affected. Non-sterile clinical immunity that protects from symptoms develops slowly and is relatively short-lived. Moreover, current malaria vaccine candidates fail to induce durable high-level protection in endemic settings, possibly due to the immunomodulatory effects of the malaria parasite itself. Because dendritic cells play a crucial role in initiating immune responses, the aim of this study was to better understand the impact of cumulative malaria exposure as well as concurrent P. falciparum infection on dendritic cell phenotype and function. METHODS: In this cross-sectional study, the phenotype and function of dendritic cells freshly isolated from peripheral blood samples of Malian adults with a lifelong history of malaria exposure who were either uninfected (n = 27) or asymptomatically infected with P. falciparum (n = 8) was assessed. Additionally, plasma cytokine and chemokine levels were measured in these adults and in Malian children (n = 19) with acute symptomatic malaria. RESULTS: With the exception of lower plasmacytoid dendritic cell frequencies in asymptomatically infected Malian adults, peripheral blood dendritic cell subset frequencies and HLA-DR surface expression did not differ by infection status. Peripheral blood myeloid dendritic cells of uninfected Malian adults responded to in vitro stimulation with P. falciparum blood-stage parasites by up-regulating the costimulatory molecules HLA-DR, CD80, CD86 and CD40 and secreting IL-10, CXCL9 and CXCL10. In contrast, myeloid dendritic cells of asymptomatically infected Malian adults exhibited no significant responses above the uninfected red blood cell control. IL-10 and CXCL9 plasma levels were elevated in both asymptomatic adults and children with acute malaria. CONCLUSIONS: The findings of this study indicate that myeloid dendritic cells of uninfected adults with a lifelong history of malaria exposure are able to up-regulate co-stimulatory molecules and produce cytokines. Whether mDCs of malaria-exposed individuals are efficient antigen-presenting cells capable of mounting an appropriate immune response remains to be determined. The data also highlights IL-10 and CXCL9 as important factors in both asymptomatic and acute malaria and add to the understanding of asymptomatic P. falciparum infections in malaria-endemic areas.
BACKGROUND:Plasmodium falciparum causes the majority of malaria cases worldwide and children in sub-Saharan Africa are the most vulnerable group affected. Non-sterile clinical immunity that protects from symptoms develops slowly and is relatively short-lived. Moreover, current malaria vaccine candidates fail to induce durable high-level protection in endemic settings, possibly due to the immunomodulatory effects of the malaria parasite itself. Because dendritic cells play a crucial role in initiating immune responses, the aim of this study was to better understand the impact of cumulative malaria exposure as well as concurrent P. falciparum infection on dendritic cell phenotype and function. METHODS: In this cross-sectional study, the phenotype and function of dendritic cells freshly isolated from peripheral blood samples of Malian adults with a lifelong history of malaria exposure who were either uninfected (n = 27) or asymptomatically infected with P. falciparum (n = 8) was assessed. Additionally, plasma cytokine and chemokine levels were measured in these adults and in Malian children (n = 19) with acute symptomatic malaria. RESULTS: With the exception of lower plasmacytoid dendritic cell frequencies in asymptomatically infected Malian adults, peripheral blood dendritic cell subset frequencies and HLA-DR surface expression did not differ by infection status. Peripheral blood myeloid dendritic cells of uninfected Malian adults responded to in vitro stimulation with P. falciparum blood-stage parasites by up-regulating the costimulatory molecules HLA-DR, CD80, CD86 and CD40 and secreting IL-10, CXCL9 and CXCL10. In contrast, myeloid dendritic cells of asymptomatically infected Malian adults exhibited no significant responses above the uninfected red blood cell control. IL-10 and CXCL9 plasma levels were elevated in both asymptomatic adults and children with acute malaria. CONCLUSIONS: The findings of this study indicate that myeloid dendritic cells of uninfected adults with a lifelong history of malaria exposure are able to up-regulate co-stimulatory molecules and produce cytokines. Whether mDCs of malaria-exposed individuals are efficient antigen-presenting cells capable of mounting an appropriate immune response remains to be determined. The data also highlights IL-10 and CXCL9 as important factors in both asymptomatic and acute malaria and add to the understanding of asymptomatic P. falciparum infections in malaria-endemic areas.
Authors: Diana Mittag; Anna I Proietto; Thomas Loudovaris; Stuart I Mannering; David Vremec; Ken Shortman; Li Wu; Leonard C Harrison Journal: J Immunol Date: 2011-04-22 Impact factor: 5.422
Authors: Anton Götz; Mei San Tang; Maureen C Ty; Charles Arama; Aissata Ongoiba; Didier Doumtabe; Boubacar Traore; Peter D Crompton; P'ng Loke; Ana Rodriguez Journal: Proc Natl Acad Sci U S A Date: 2017-11-21 Impact factor: 11.205
Authors: Lisa J Ioannidis; Catherine Q Nie; Ann Ly; Victoria Ryg-Cornejo; Chris Y Chiu; Diana S Hansen Journal: J Immunol Date: 2015-12-30 Impact factor: 5.422
Authors: Salenna R Elliott; Timothy P Spurck; Joelle M Dodin; Alexander G Maier; Till S Voss; Francisca Yosaatmadja; Paul D Payne; Geoffrey I McFadden; Alan F Cowman; Stephen J Rogerson; Louis Schofield; Graham V Brown Journal: Infect Immun Date: 2007-04-30 Impact factor: 3.441
Authors: Tapio Lönnberg; Valentine Svensson; Kylie R James; Daniel Fernandez-Ruiz; Ismail Sebina; Ruddy Montandon; Megan S F Soon; Lily G Fogg; Arya Sheela Nair; Urijah Liligeto; Michael J T Stubbington; Lam-Ha Ly; Frederik Otzen Bagger; Max Zwiessele; Neil D Lawrence; Fernando Souza-Fonseca-Guimaraes; Patrick T Bunn; Christian R Engwerda; William R Heath; Oliver Billker; Oliver Stegle; Ashraful Haque; Sarah A Teichmann Journal: Sci Immunol Date: 2017-03-03
Authors: Jessica R Loughland; Gabriela Minigo; Derek S Sarovich; Matt Field; Peta E Tipping; Marcela Montes de Oca; Kim A Piera; Fiona H Amante; Bridget E Barber; Matthew J Grigg; Timothy William; Michael F Good; Denise L Doolan; Christian R Engwerda; Nicholas M Anstey; James S McCarthy; Tonia Woodberry Journal: Sci Rep Date: 2017-06-01 Impact factor: 4.379
Authors: Angela D Pack; Patrick V Schwartzhoff; Zeb R Zacharias; Daniel Fernandez-Ruiz; William R Heath; Prajwal Gurung; Kevin L Legge; Chris J Janse; Noah S Butler Journal: Cell Rep Date: 2021-08-24 Impact factor: 9.423